2256.HK
Abbisko Cayman Limited

Healthcare · Biotechnology · valued as of 2026-11-03 · statements 2025-12-31

Average Intrinsic Value

275.12M USD

Market Cap

800.62M USD

Margin of Safety

-191.0%

Intrinsic / Market Ratio

0.34×

Projections, not exact values. Intrinsic Values are projected from each company's past reports. They show which stocks look cheap compared with the others, not exactly what a stock is worth.

How Each Value Is Built

The screener's three formulas on the reported figures. Each card reads the same way: the value as a sum of numbered terms, each term's calculation opened under it, from the reported figures to the value. The list ranks companies by their plain average over the market cap.

EPV + Growth

275.12M USD

what the normal year's earnings are worth for ever, plus growth that pays

Profit

275.12M USD

15 years of cash the shareholders can take out, and the equity left at year 15

FCFF

275.12M USD

15 years of cash for shareholders and lenders, less what is owed

Intrinsic Value

275.12M USD

the plain average of the three, uncapped, as the screener averages them

Intrinsic Value

275.12M USD

from the sum above

Market Cap

800.62M USD

the price on the date above times the shares

Intrinsic Value ÷ Market Cap

0.34×

the ratio the screener ranks by; Margin of Safety -191.0% (1 − Market Cap ÷ Intrinsic Value)

Each card below builds one of the three values from the reported years.

Earnings power value plus growth: 275.12M USD
What the normal year's operating profit after tax is worth if it lasts for ever, plus what the new investment adds beyond its cost, less the net debt that comes before the shareholders (or plus the net cash).

The earnings power value was not computed (a normalized NOPAT at or below zero), so the value is the book value today, 275.12M USD.

Market value

Market Cap800.62M USD

The price on the date above times the shares.

Value vs market

Margin of Safety-191.0%

1 minus the market cap as a share of the value.

Profit value: today's value of the shareholders' equity, from the cash it can pay them (FCFE): 275.12M USD
Fifteen years of free cash flow to equity (FCFE), each brought to today at the cost of equity, plus the equity at year 15 brought to today.

The projection was not made (a profit at or below zero in the latest three years), so the value is the book value today, 275.12M USD, as the screener leaves it.

①Present Value of the 15 Years of FCFE

Not in the value

②Equity at Year 15, Today

Not in the value

Market value

Market Cap800.62M USD

The price on the date above times the shares.

Value vs market

Margin of Safety-191.0%

1 minus the market cap as a share of the value.

FCFF value: today's value of the shareholders' equity, from the cash the firm can pay its shareholders and lenders (FCFF): 275.12M USD
Fifteen years of free cash flow to the firm (FCFF), each brought to today at the WACC, plus the invested capital at year 15 brought to today, less the net debt today (or plus the net cash).

The projection was not made (an operating profit at or below zero in the latest three years), so the value is the book value today, 275.12M USD, as the screener leaves it.

①Present Value of the 15 Years of FCFF

Not in the value

②Invested Capital at Year 15, Today

Not in the value

③Net Cash Today

Not in the value

Market value

Market Cap800.62M USD

The price on the date above times the shares.

Value vs market

Margin of Safety-191.0%

1 minus the market cap as a share of the value.

The Rates and the Capital the Values Read

The WACC and the cost of equity each value is discounted at, the book value and the net debt each starts from, and the seven quality metrics, from the same run.

WACC: 11.04%
Cost of Equity =Risk-Free Rate 4.50%+Beta 1.19×Market Risk Premium 6.00%= 11.61%

The yearly return the shareholders require for the risk they carry; it is the rate that brings their future cash to today.

Tax Rate for WACC =Tax Provision 8.76M USDPretax Income 16.66M USD= 52.56%

The tax the interest saves.

Interest Expense =EBIT 17.14M USD−Pretax Income 16.66M USD= 477.03K USD

The interest the company paid: EBIT is the profit before tax plus the interest.

Cost of Debt =Interest Expense 477.03K USDTotal Debt 43.42M USD×(1 − Tax Rate for WACC 52.56%)= 0.52%

What the lenders are paid a year after the tax the interest saves.

Debt Weight =Total Debt 43.42M USDMarket Cap + Total Debt 800.62M USD + 43.42M USD= 5.14%

The part of the capital the lenders put in, at market value.

WACC =Equity Weight 94.86%×Cost of Equity 11.61%+Debt Weight 5.14%×Cost of Debt 0.52%= 11.04%

Weighted average cost of capital: the yearly return the shareholders and the lenders together require, weighted by what each puts in; the rate that brings the firm's future cash to today.

Book value and net debt today
Both from the balance sheet of the newest quarter, 2025-12-31.

Total Assets 336.68M USD − Total Liabilities 61.56M USD = Book Value Today 275.12M USD

Total Debt 43.42M USD − Cash and Short-Term Investments 300.39M USD = Net Debt Today -256.97M USD

The book value is what Profit starts from and what stands when a projection is not made; the book value plus the net debt is what FCFF starts from; the net debt comes off Greenwald's and FCFF's values before the shareholders.

Quality metrics
Read beside the value, never a condition for it: every company is valued, and a filter in the list is the reader's choice.
MetricFrom
Share dilutionShares Today ÷ Shares Two Years Back − 12.4%at most 5%passes663,578,350 / 647,858,444
Accrual quality(Operating Cash Flow − Net Income) ÷ Total Assets1.0%at least -10.0%passes(11.34M USD − 7.90M USD) ÷ 336.68M USD
Price to bookMarket Cap ÷ Book Value Today2.91×at most 3×passes800.62M USD ÷ 275.12M USD
Operating marginOperating Income ÷ Revenue7.0%above 10.0%does not pass6.11M USD ÷ 87.58M USD
Revenue growthRevenue ÷ Revenue a Year Before − 126.7%above 10.0%passes87.58M USD / 69.13M USD
Net cash(Cash − Total Debt) ÷ Market Cap8.0%above -30%passes(107.17M USD − 43.42M USD) ÷ 800.62M USD
Operating efficiencyOperating Income ÷ Gross Profit7.0%above 25.0%does not pass6.11M USD ÷ 87.58M USD

Market Data

The provider's ratios and the analysts' consensus beside the argument; none of them enters a value.

Share price

8.76 HKD

Enterprise value

4.26B HKD

the provider's own figure

EV / EBITDA

-8.38×

Price / book

2.46×

the provider's book

Price / earnings

—

Return on equity

-21.2%

the provider's figure, not this page's

Profit margin

0.0%

Revenue growth

-84.1%

Analyst target, mean

21.75 HKD

Analysts

6

opinions in the consensus

Financial Statements

The annual lines the screener holds, year by year, in USD at each period's rate; the figures this valuation read are in its calculation above.

USD2022202320242025
Income statement

Revenue

02.68M69.13M87.58M

Gross profit

02.68M69.13M87.58M

Operating income

-69.96M-69.00M-1.15M6.11M

EBITDA

operating income before depreciation and amortisation

-68.59M-57.89M14.16M20.33M

Pretax income

-71.25M-60.79M10.70M16.66M

Net income

-71.25M-60.79M3.88M7.90M

Normalized income

net income without one-off items, as the data provider prints it; Profit's line when printed

-71.25M-60.89M4.14M7.69M

R&D

54.45M61.09M61.91M72.75M
Balance sheet, year end

Total assets

357.89M297.95M289.00M336.68M

Total liabilities

20.58M18.91M20.40M61.56M

Shareholders' equity

the equity the parent's shareholders own, as printed, without minority interest; the book value the values read is total assets less total liabilities, in Book Value and Net Debt above

337.31M279.03M268.60M275.12M

Total debt

6.55M5.03M3.33M43.42M

Cash and equivalents

92.27M81.42M39.71M107.17M

Net PP&E

fixed assets after depreciation

11.11M9.77M7.24M4.62M

Working capital

current assets less current liabilities

330.67M272.15M258.54M243.26M
Cash flow

Operating cash flow

-49.44M-62.64M-1.77M11.34M

Capital expenditure

paid out, so below zero

-3.27M-1.73M-1.01M-791.52K

Depreciation and amortisation

2.27M2.59M3.23M3.19M

Free cash flow

operating cash flow plus capital expenditure

-52.71M-64.36M-2.79M10.55M